Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16005947rdf:typepubmed:Citationlld:pubmed
pubmed-article:16005947lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16005947lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:16005947lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:16005947lifeskim:mentionsumls-concept:C0042149lld:lifeskim
pubmed-article:16005947lifeskim:mentionsumls-concept:C0334359lld:lifeskim
pubmed-article:16005947lifeskim:mentionsumls-concept:C0184511lld:lifeskim
pubmed-article:16005947lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:16005947lifeskim:mentionsumls-concept:C0441766lld:lifeskim
pubmed-article:16005947lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:16005947lifeskim:mentionsumls-concept:C1514162lld:lifeskim
pubmed-article:16005947lifeskim:mentionsumls-concept:C1522673lld:lifeskim
pubmed-article:16005947pubmed:issue3lld:pubmed
pubmed-article:16005947pubmed:dateCreated2005-8-22lld:pubmed
pubmed-article:16005947pubmed:abstractTextUterine papillary serous carcinoma (UPSC) is an aggressive form of endometrial cancer characterized by a high recurrence rate and a poor prognosis. Prior studies evaluating treatment of UPSC have been limited by small numbers of patients and inclusion of partially staged patients. The purpose of this study was to evaluate the efficacy of adjuvant platinum-based chemotherapy and vaginal cuff radiation in a large cohort of surgical stage I UPSC patients.lld:pubmed
pubmed-article:16005947pubmed:languageenglld:pubmed
pubmed-article:16005947pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16005947pubmed:citationSubsetIMlld:pubmed
pubmed-article:16005947pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16005947pubmed:statusMEDLINElld:pubmed
pubmed-article:16005947pubmed:monthSeplld:pubmed
pubmed-article:16005947pubmed:issn0090-8258lld:pubmed
pubmed-article:16005947pubmed:authorpubmed-author:FoxP WPWlld:pubmed
pubmed-article:16005947pubmed:authorpubmed-author:SchwartzPeter...lld:pubmed
pubmed-article:16005947pubmed:authorpubmed-author:YuHerbertHlld:pubmed
pubmed-article:16005947pubmed:authorpubmed-author:RutherfordTho...lld:pubmed
pubmed-article:16005947pubmed:authorpubmed-author:KellyMichael...lld:pubmed
pubmed-article:16005947pubmed:authorpubmed-author:McAlpineJessi...lld:pubmed
pubmed-article:16005947pubmed:authorpubmed-author:AzodiMasoudMlld:pubmed
pubmed-article:16005947pubmed:authorpubmed-author:O'malleyDavid...lld:pubmed
pubmed-article:16005947pubmed:issnTypePrintlld:pubmed
pubmed-article:16005947pubmed:volume98lld:pubmed
pubmed-article:16005947pubmed:ownerNLMlld:pubmed
pubmed-article:16005947pubmed:authorsCompleteYlld:pubmed
pubmed-article:16005947pubmed:pagination353-9lld:pubmed
pubmed-article:16005947pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:meshHeadingpubmed-meshheading:16005947...lld:pubmed
pubmed-article:16005947pubmed:year2005lld:pubmed
pubmed-article:16005947pubmed:articleTitleImproved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.lld:pubmed
pubmed-article:16005947pubmed:affiliationDivision of Gynecology Oncology, Department of Obstetrics and Gynecology and Pathology, Yale University School of Medicine, New Haven, CT 06520-8063, USA. m.kelly@yale.edulld:pubmed
pubmed-article:16005947pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16005947pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16005947lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16005947lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16005947lld:pubmed